Latest News and Press Releases

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Gabapentin Enacarbil (CAS 478296-72-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added...

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Gabapentin (CAS 60142-96-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form, By Type, By Application, By Distribution Channel, By Region, And Segment...

Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application,...

New York, USA, July 11, 2023 (GLOBE NEWSWIRE) -- Gabapentin Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Gabapentin Market Information By...

Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Global Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Regional Outlook and...

Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Multiple System Atrophy (MSA) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...

Pune, March 24, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Gabapentin Market” Research Report 2022-2027 is a historical...

West Palm Beach, FL, March 19, 2018 (GLOBE NEWSWIRE) -- For the first time, a groundbreaking new study is going to be conducted at a national treatment center. Ambrosia Treatment Center announced...

NEW YORK, July 20, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...